|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004238,
umls-concept:C0008976,
umls-concept:C0036043,
umls-concept:C0038454,
umls-concept:C0043031,
umls-concept:C0199176,
umls-concept:C0441889,
umls-concept:C0525032,
umls-concept:C0936012,
umls-concept:C1707455,
umls-concept:C2348066,
umls-concept:C2587213
|
|
pubmed:issue |
9745
|
|
pubmed:dateCreated |
2010-9-20
|
|
pubmed:abstractText |
Effectiveness and safety of warfarin is associated with the time in therapeutic range (TTR) with an international normalised ratio (INR) of 2·0-3·0. In the Randomised Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial, dabigatran versus warfarin reduced both stroke and haemorrhage. We aimed to investigate the primary and secondary outcomes of the RE-LY trial in relation to each centre's mean TTR (cTTR) in the warfarin population.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:AlingsMarcoM,
pubmed-author:ConnollyStuart JSJ,
pubmed-author:DansAntonioA,
pubmed-author:EikelboomJohnJ,
pubmed-author:EzekowitzMichael DMD,
pubmed-author:FlatherMarcusM,
pubmed-author:FranzosiMaria GraziaMG,
pubmed-author:OldgrenJonasJ,
pubmed-author:PaisPremP,
pubmed-author:PogueJaniceJ,
pubmed-author:RE-LY investigators,
pubmed-author:ReillyPaul APA,
pubmed-author:WallentinLarsL,
pubmed-author:YangSeanS,
pubmed-author:YusufSalimS
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
376
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
975-83
|
|
pubmed:dateRevised |
2011-2-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20801496-Administration, Oral,
pubmed-meshheading:20801496-Adult,
pubmed-meshheading:20801496-Aged,
pubmed-meshheading:20801496-Anticoagulants,
pubmed-meshheading:20801496-Atrial Fibrillation,
pubmed-meshheading:20801496-Benzimidazoles,
pubmed-meshheading:20801496-Drug Administration Schedule,
pubmed-meshheading:20801496-Female,
pubmed-meshheading:20801496-Hemorrhage,
pubmed-meshheading:20801496-Humans,
pubmed-meshheading:20801496-International Normalized Ratio,
pubmed-meshheading:20801496-Male,
pubmed-meshheading:20801496-Middle Aged,
pubmed-meshheading:20801496-Pyridines,
pubmed-meshheading:20801496-Stroke,
pubmed-meshheading:20801496-Thromboembolism,
pubmed-meshheading:20801496-Treatment Outcome,
pubmed-meshheading:20801496-Warfarin
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
|
|
pubmed:affiliation |
Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden. lars.wallentin@ucr.uu.se
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
